Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. H&R Block is a tax preparation and financial services company that has been providing its ...

Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control treatment — are simultaneously evaluated in two or more arms of the trial, with ...

This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...

Collectors keep pushing prices higher for 1968 Camaro SS big-block cars, and the gap over small-block examples keeps widening. Buyers pay a premium for the extra cubes, the factory performance image, ...

Doctors are no longer just warning that plastic is everywhere in the environment. They are now literally finding tiny ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Investopedia / Madelyn Goodnight Block policies provide all-risk coverage for goods in ...

On November 19, Block Inc. held its first Investor Day in three years. Jack Dorsey, the company’s cofounder, chief executive, and “Block Head,” took to the stage and summarily posed what many ...

Discover five foods with greater blood pressure benefits than beets, providing steady, long-lasting support for your heart and overall health.

Ezekiel bread has the benefit of sprouted grains, which support your gut-health. Learn more about the potential benefits and risks of this bread.

This important study combines optogenetic manipulations and wide-field imaging to show that the retrosplenial cortex controls behavioral responses to whisker deflection in a context-dependent manner.

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.